The Bland Company
London, UK· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A drug delivery specialist developing advanced formulation technologies for biologics and complex therapeutics.
ImmunologyOncologyMetabolic
Technology Platform
Proprietary polymer-based and conjugation platforms for the targeted, sustained, and non-invasive delivery of biologic drugs.
Opportunities
Potential to unlock new therapeutic applications for biologics by solving key delivery challenges.
Risk Factors
Risk of technological obsolescence if new modalities (e.g., cell therapies) reduce reliance on traditional protein delivery.
Competitive Landscape
Operates in a competitive but fragmented field of drug delivery, requiring continuous innovation to maintain a technological edge.